GHRH and cancer: At the same time, agonistic analogs were developed to evaluate their potential clinical applications, particularly in conditions where GH deficiency played a critical role [13–15]With interest in the possible roles of GHRH in carcinogenesis, our research group began synthesizing antagonistic analogs of GHRH to evaluate the use of cancer therapy.